Eli Lilly expands $2.75B AI-enabled drug discovery deal with Insilico Medicine
Eli Lilly extends $2.75 billion AI-based drug discovery deal with Insilico Medicine Eli Lilly and Insilico Medicine have announced an expansion of their existing collaboration, aiming to drive AI-powered drug discovery. The new deal worth up to $2.75 billion will focus on financial assistance, regulatory and commercial cooperation. Under the recent agreement, Insilico will receive…

